Eryseng parvo

Each 2 ml dose contains:  
Active substances: 
- Inactivated porcine parvovirus, strain NADL-2 - PR >1.15*  
- Inactivated *Erysipelothrix rhusiopathiae*, strain R32E11 - ELISA >3.34 log₂ IE₅₀%**  

\*PR: relative potency (ELISA)  
\*\*IE₅₀%: ELISA inhibition - 50%  

Adjuvants: 
- Aluminum hydroxide - 5.29 mg (aluminum)  
- DEAE-dextran  
- Ginseng  

For the active immunization of female pigs to protect their offspring against transplacental infection caused by porcine parvovirus.  
For the active immunization of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotypes 1 and 2.  

Onset of immunity:
- Porcine parvovirus: From the beginning of the gestation period.  
- E. rhusiopathiae: Three weeks after completing the primary vaccination schedule.  

Duration of immunity: 
- Porcine parvovirus: Vaccination ensures fetal protection throughout gestation. Revaccination should be performed before each gestation.  
- E. rhusiopathiae: Vaccination provides protection against swine erysipelas until the recommended revaccination period.

Intramuscular use.  
Administer a 2 ml dose via intramuscular injection into the neck muscles according to the following schedule:  

Primary vaccination:  
For pigs aged 6 months and older that have not been previously vaccinated with the product, administer two injections 3-4 weeks apart. The second injection must be given 3-4 weeks before mating.  

Revaccination:  
Administer a single injection 2-3 weeks before each subsequent mating, approximately every 6 months.  

Simultaneous use with UNISTRAIN PRRS:
For breeding sows aged 6 months and older, the combined products ERYSENG PARVO and UNISTRAIN PRRS should only be used if the animals are vaccinated before mating.  

Follow these instructions:  
The contents of one vial of UNISTRAIN PRRS must be mixed with the contents of one vial of ERYSENG PARVO. A single 2 ml dose of the combined vaccine must be injected intramuscularly within 2 hours.  

Combination schedule:  
- UNISTRAIN PRRS (10 doses) + ERYSENG PARVO (10 doses) = 20 ml  
- UNISTRAIN PRRS (25 doses) + ERYSENG PARVO (25 doses) = 50 ml  
- UNISTRAIN PRRS (50 doses) + ERYSENG PARVO (50 doses) = 100 ml  

Before administration, allow the vaccine to reach room temperature (15-25°C). Shake well before use.

Do not use in cases of hypersensitivity to the active substances, adjuvants, or any of the excipients.

Zero days.

Type I clear glass vials of 20, 50, and 100 ml, sealed with rubber stoppers and aluminum caps.  
PET polyethylene vials of 20, 50, 100, and 250 ml.  

Packaging sizes: 
- Carton box with 1 glass vial of 10 doses (20 ml)  
- Carton box with 1 glass vial of 25 doses (50 ml)  
- Carton box with 1 glass vial of 50 doses (100 ml)  
- Carton box with 1 PET vial of 10 doses (20 ml)  
- Carton box with 1 PET vial of 25 doses (50 ml)  
- Carton box with 1 PET vial of 50 doses (100 ml)  
- Carton box with 1 PET vial of 125 doses (250 ml)  

*Not all packaging sizes may be marketed.

Store and transport under refrigerated conditions at 2°C - 8°C.
Do not freeze.
Protect from light.

2 years from the date of production, expiry time after mixing with UNISTRAIN PRRS: 2 hours.

Do not use after the expiry date indicated on the packaging.